Regulations
Latin America (LATAM) presents a wealth of opportunity for medical device manufacturers, but establishing market success requires navigating complex independent regulatory landscapes LATAM Medical Device Registration strategy rather than a single consolidated system. Each country operates under its own Ministry of Health, utilizes distinct languages primarily Spanish and Portuguese and enforces specific legal frameworks. To successfully commercialize products, companies must align with the accurate standards of national agencies such as ANVISA medical device registration in Brazil, COFEPRIS in Mexico, INVIMA in Colombia, and ANMAT in Argentina. Attempting to enter these markets without a localized strategic plan often leads to prohibitive costs and extensive technical delays.
The specific technical standards for each jurisdiction, as requirements are frequently updated to align with international benchmarks. In Brazil, compliance on RDC 751/2022 and the newer RDC 848/2024, which establishes essential safety and performance requirements; high-risk devices must also secure Brazilian Good Manufacturing Practices (BGMP) certification. Meanwhile, Mexico has modernized its approach through COFEPRIS medical device registration, offering a 30-day fast-track "equivalency" pathway for devices already approved by the FDA or EU. In Colombia, INVIMA now mandates Unique Device Identification (UDI) as of 2026, while Argentina’s ANMAT medical device registration requires a local Authorized Agent and a technical review process that can last up to 18 months. Navigating these requirements demands meticulous technical documentation and constant monitoring of regulatory shifts.
At Morulaa Health Tech, we serve as your consolidated regulatory partner for LATAM Medical Device Registration. We prepare your technical dossiers, coordinate closely with your chosen local entities, and manage your product lifecycles across the entire region to ensure continuous compliance.
LATAM MEDICAL DEVICE REGISTRATION SERVICES BY COUNTRY
We provide localized expertise and technical documentation support Personalized to the specific legal frameworks of your target markets are :
BRAZIL MEDICAL DEVICE REGISTRATION
To market medical devices in Brazil, companies must comply with ANVISA medical device registration regulations, specifically RDC 751/2022 and the newer RDC 848/2024. The approval process is dictated by a four-tier risk classification system (Class I to IV) based on the device's invasiveness and intended use.
Class I (Low Risk) and Class II (Medium Risk) follow a simplified pathway called Notification (Cadastro). Class I products often receive immediate electronic approval, while Class II reviews typically take around 30 to 90 business days and Class I and II fees range from 1,500 to 3,000 BRL. These categories require basic technical documentation and adherence to Brazilian labeling standards.
Class III (High Risk) and Class IV (Very High Risk) require a more exact registration (Registro) process take 250 days and government fees can be, then 49,000 BRL. This involves a comprehensive technical dossier, clinical data evidence, and a full review by ANVISA medical device registration. Most importantly, these high-risk classes must obtain Good Manufacturing Practice (GMP) certification, which verifies that the manufacturer meets exact quality standards.
Entering the Brazilian market depends on specific classification. Misclassifying a device or providing incomplete clinical data are common pitfalls that lead to significant delays. Manufacturers must ensure all technical files, sterilization validations, and instructions are localized and aligned with international standards like ISO 13485. By following these requirements, companies ensure patient safety and gain efficient access through Brazil medical device registration to one of the largest healthcare markets in Latin America.
MEXICO MEDICAL DEVICE REGISTRATION
The process of obtaining a Sanitary Registration (Registro Sanitario) is a mandatory regulatory requirement for the commercialization of medical devices in Mexico. COFEPRIS medical device registration (Federal Commission for the Protection against Sanitary Risks) is the governing body that evaluates these submissions to ensure safety and efficacy.
COFEPRIS (the Federal Commission for the Protection against Sanitary Risks) serves as Mexico’s primary health regulatory authority, functioning much like the FDA in the United States. For medical device manufacturers, this agency is the gatekeeper to the Mexican market, overseeing everything from risk-based product classification to facility compliance and post-market safety. Since 2025, the agency has significantly modernized its approach by aligning with international standards like the IMDRF and MDSAP. This shift highlighted by the launch of an abbreviated "equivalency" pathway allows companies with existing FDA or EU approvals to bypass full technical dossiers in favor of a 30-day fast-track review.For devices that are the riskiest, like Class III it can take up to 60 business days. For devices that are high risk, like Class III, COFEPRIS medical device registration can take up to 60 business days.
The cost for a new Mexico Medical Device Registration is determined by the device's risk classification. The government fees for an initial application are $16,499 MXN for Class I (Low Risk), $24,198 MXN for Class II, and $30,798 MXN for Class III. If you are renewing an existing registration, the cost is reduced to 75% of the original fee, resulting in the figures you likely encountered: $12,374 MXN for Class I, $18,149 MXN for Class II, and $23,098 MXN for Class III. It is important to note that these values are in Mexican Pesos.
Operating under a three-tiered risk system, COFEPRIS requires foreign manufacturers to appoint a local Mexico Registration Holder (MRH) and maintain strict adherence to Spanish-language labeling and quality management standards (NOM-241). Recent 2026 reforms have further streamlined the landscape by extending registration renewals to ten years and reducing bureaucratic wait times for low-risk devices. For international firms, navigating these requirements is most effective when integrated into a broader operational strategy, often utilizing local manufacturing partnerships to manage infrastructure while maintaining direct control over the technical and regulatory approval process.
COLOMBIA MEDICAL DEVICE REGISTRATION
The Colombia medical device registration process in Colombia is managed by the National Food and Drug Surveillance Institute (INVIMA). Under the guidelines established by Decree 4725 of 2005, all medical devices must obtain a sanitary registry before they can be imported, sold, or distributed within the country. Devices are categorized based on their level of risk into four distinct groups: Class I (low risk), Class IIa (moderate risk), Class IIb (high risk), and Class III (very high risk). For international manufacturers, the first critical step is to appoint a local legal representative or a licensed importer based in Colombia to act as the official registration holder.
The approval for Colombia medical device registration varies significantly depending on the device's classification. For Class I and IIa products, INVIMA utilizes an "automatic" registration system, where the certificate is issued shortly after the application is submitted, provided all legal and technical documents are in order. Conversely, Class IIb and III devices must undergo a technical and scientific evaluation, a detailed review process of lower-risk products, processing Class I and IIa devices in just 2-4 days. Class IIb and III devices undergo a 4-6 month review and highly accessible fees ranging from USD 750 (Class I/IIa) to USD 850 (Class IIb/III).
Key documentation required for a successful submission includes a Certificate of Free Sale (CFS) from a recognized global market, evidence of ISO 13485 certification, and comprehensive technical data sheets translated into Spanish. As of 2026, compliance with Unique Device Identification (UDI) standards is also mandatory for tracking and safety. Once approved, the registry remains valid for ten years, though the holder must comply with ongoing "Technovigilance" reporting to monitor any adverse events or field safety notices.
ARGENTINA MEDICAL DEVICE REGISTRATION
To legally sell medical equipment in Argentina, companies must adhere to the regulations enforced by the National Administration of Drugs, Foods, and Medical Technology (ANMAT). Under Mercosur standards, devices are categorized into four classes (I-IV) based on risk levels. All manufacturers must demonstrate compliance with ISO 13485:2016 and local Good Manufacturing Practices (GMP).
A critical requirement for ANMAT medical device registration is the appointment of a local Authorized Agent in Argentina (AAR). This agent serves as the legal registration holder and the primary liaison with ANMAT medical device registration. It is vital to choose a reliable partner, as terminating a relationship with an AAR typically invalid the registration, requiring the manufacturer to restart the entire application process.
The registration journey begins with a formal submission by the AAR, followed by a technical evaluation of safety and efficacy. High-risk devices (Classes III and IV) usually undergo a site inspection to verify manufacturing standards. While the legal review timeframe is 180 days, the actual process of ANMAT medical device registration often takes 12 to 18 months. Once approved, the certificate remains valid for five years, provided a renewal is requested at least 90 days before expiration. Additionally, all technical documentation, labeling, and instructions for use must be provided in Spanish. Any significant modifications to the product’s design or production must be approved by ANMAT before the updated device can be marketed.
COSTA RICA MEDICAL DEVICE REGISTRATION
To register medical devices in Costa Rica, companies must follow the regulations set by the Ministerio de Salud (Ministry of Health). Locally, these products are categorized as Biomedical Equipment and Materials (EMB). The LATAM Medical Device Registration process is determined by a four-tier risk classification system, which closely aligns with Health Canada standards.
Class 1 devices are generally exempt from registration. Class 2 devices follow a simplified process, while Class 3 and 4 (high-risk) require more accurate documentation, including clinical trial summaries and post-market surveillance plans. Notably, if a high-risk device already holds US FDA clearance, it may qualify for a faster, simplified registration pathway.
All applicants must provide a notarized Free Sale Certificate from the country of origin to prove the device is legally marketed elsewhere. Additionally, technical specifications, sterilization details, and instructions must be provided, with all labeling required to be in Spanish.
The Ministry reviews applications in two stages: a Legal Review (Phase 1) followed by a Technical Review (Phase 2). Once the Ministry confirms compliance, they issue a registration certificate that remains valid for 5 years. Navigating these requirements accurately is essential for any manufacturer looking to enter the Costa Rican healthcare market.
Costa Rica medical device registration can take a time usually around 6 to 8 months but Costa Rica medical device registration can be faster for devices that are already approved in the United States.
PUERTO RICO MEDICAL DEVICE REGISTRATION
Puerto Rico is a U.S. territory, LATAM Medical Device Registration is handled through a two-tier system led by federal law. All devices must first meet U.S. Food and Drug Administration (FDA) requirements, which include obtaining a 510(k) clearance, PMA approval, or an exemption, as well as completing formal establishment registration and product listing. On a local level, the Puerto Rico Department of Health (PRDoH) oversees the physical distribution of these products; companies must secure local permits and licenses to sell or store medical equipment on the island. While federal rules require labeling in English, it is standard practice and often a local requirement for patient safety to provide labeling and Instructions for Use (IFU) in Spanish to ensure the local population can use the devices correctly.
The FDA establishment registration fee is $11,423, a mandatory annual cost for most facilities that is not eligible for small business discounts. For product clearance, a standard 510(k) submission costs $26,067, while a high-risk Premarket Approval (PMA) application reaches $579,272; however, businesses certified under the Small Business Determination (SBD) program pay significantly reduced rates, such as $6,517 for a 510(k).
The FDA timeline typically aims for a 90-day goal for 510(k) reviews and 180 days for PMAs, though the total process often extends to 6 months or more when including administrative processing and potential "requests for additional information." Locally, once federal clearance is secured, companies must factor in the Puerto Rico Department of Health licensing, which can take several months to process and involves smaller administrative fees (typically ranging from a few 100 to a few 1000 dollars) depending on the specific distributor or "Botiquín" permit required.
STRATEGIC MARKET ACCESS LATAM MEDICAL DEVICE REGISTRATION SUPPORT
One of the most critical commercial considerations when entering LATAM Medical Device Registration is maintaining regulatory independence from local distribution partners. Because regulatory bodies like ANVISA, COFEPRIS, and INVIMA require a local entity to hold your product registrations, many companies allow their commercial distributors to act as the license holders. However, this effectively gives the distributor control over your product's legal right to be in the market. If you ever decide to change partners or end the relationship, it can lead to complicated legal issues or force you to start the entire registration process over from the beginning.
At Morulaa Health Tech, we help you navigate regional challenges with a strategy designed to protect your interests and maintain control over your intellectual property. While we do not hold licenses ourselves, we provide expert support by preparing technical dossiers and collaborating with your chosen local entities to ensure a professional, seamless process. Our team assists with comprehensive document preparation including your Declaration of Conformity and essential certifications like ISO 13485 and MDSAP while managing complex localization and translation requirements for agencies such as ANVISA medical device registration in Brazil and ANMAT medical device registration in Argentina. Furthermore, we ensure your products adhere to modern standards and the latest 2026 requirements, such as Unique Device Identification (UDI) and advanced safety monitoring systems for Colombia.
Our goal is to help you build safe, flexible partnerships that allow you to grow your business across Latin America while keeping full ownership of your long-term success.
How does the new ANVISA medical device registration framework work in 2026?
Under RDC 751/2022 and RDC 848/2024, brazil medical device registration now requires a risk-based approach where Class I and II products use "Notification" for immediate access. Higher-risk Class III and IV products must undergo full ANVISA medical device registration, which mandates valid Brazil GMP evidence or an MDSAP certificate.
I want to know if I can speed up my Mexico medical device registration using the 2026 Reliance Model ?
Yes I can use the updated COFEPRIS reliance framework to do this. The COFEPRIS reliance framework now allows for a way to register my Mexico medical device if it is already approved by authorities I can trust like the FDA or Health Canada. This faster way to register my Mexico device with COFEPRIS can be finished in about 30 business days. This is possible if my Mexico medical device is the same, as the one that was already approved in another country.
What are the latest mandatory requirements for Colombia medical device registration?
As of February 2026, INVIMA has made "Semantic Standard Reporting" mandatory for all medical devices to enhance market traceability. To complete your Colombia medical device registration, the license holder must now submit UDI-DI codes through a designated web platform, as products without this report can no longer be legally commercialized.
How do I submit an ANMAT medical device registration in Argentina today?
All applications must be processed through the HELENA electronic portal by a local authorized representative. For ANMAT medical device registration, Class I and II devices typically follow a "Declaration of Conformity" route, while Class III and IV devices require a full technical evaluation of safety data, with all registrations valid for a period of 5 years.
What language and labeling rules must I follow for these LATAM markets?
Linguistic compliance is strictly enforced across the region; Brazil medical device registration requires all technical files and labels in Portuguese, while Mexico, Colombia, and Argentina require Spanish. Each regulator has specific labeling provisions such as Argentina’s Disposición 64/2025 that must be integrated into your technical dossier before submission.
ANVISA Medical Device Registration Consultant